Literature DB >> 18625693

Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation.

F Caprioli1, C Stolfi, R Caruso, D Fina, G Sica, L Biancone, F Pallone, G Monteleone.   

Abstract

OBJECTIVE: Defects in Fas-mediated apoptosis are supposed to contribute to the accumulation of T lymphocytes in the gut of patients with Crohn's disease (CD). This phenomenon has been functionally linked with the elevated expression of Flip, an inhibitor of Fas-mediated apoptosis. In this study, the molecular mechanisms that control Flip in CD were examined.
METHODS: Paired colonic biopsies of patients with CD, patients with ulcerative colitis (UC) and normal controls were analysed for Flip by real-time PCR and western blotting. Flip was also evaluated in CD3(+) lamina propria lymphocytes (T-LPLs) cultured with tosyl phenylalanyl chloromethyl ketone (TPCK; a nuclear factor-kappaB (NF-kappaB) inhibitor), AG490 (a Janus kinase 2 (Jak2)/signal transducer and activator of transcription (Stat) inhibitor) or 17-desmethoxy-17-N,N-dimethylamino-geldanamycin (DMAG; an inhibitor of heat shock protein 90). The rate of apoptosis was examined by flow cytometry.
RESULTS: In CD, upregulation of Flip occurred at both the RNA and protein level. Treatment of CD CD3(+) T-LPLs with TPCK or AG490 markedly reduced Flip RNA, suggesting a role for NF-kappaB and Jak/Stat pathways in the transcriptional control of Flip in this condition. Consistently, both TPCK and AG490 sensitised CD T-LPLs to Fas-mediated apoptosis. Flip protein in cells from normal gut was rapidly degraded by the proteasome pathway. In contrast, in inflamed gut of both CD and UC patients, there was a reduced degradation of Flip via the ubiquitin-proteasome-dependent pathway, but Flip expression can be decreased by DMAG.
CONCLUSIONS: The data demonstrate that Flip is regulated at both the transcriptional and post-translational level in CD, and indicate that in the normal but not inflamed gut Flip is degraded via the ubiquitin-proteasome-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625693     DOI: 10.1136/gut.2008.149286

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  5 in total

1.  miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.

Authors:  Mehmet Coskun; Jacob Tveiten Bjerrum; Jakob Benedict Seidelin; Jesper Thorvald Troelsen; Jørgen Olsen; Ole Haagen Nielsen
Journal:  World J Gastroenterol       Date:  2013-07-21       Impact factor: 5.742

Review 2.  Molecular pathways driving disease-specific alterations of intestinal epithelial cells.

Authors:  Rocío López-Posadas; Markus F Neurath; Imke Atreya
Journal:  Cell Mol Life Sci       Date:  2016-09-13       Impact factor: 9.261

3.  ERK controls epithelial cell death receptor signalling and cellular FLICE-like inhibitory protein (c-FLIP) in ulcerative colitis.

Authors:  Jakob Benedict Seidelin; Mehmet Coskun; Ben Vainer; Lene Riis; Christoffer Soendergaard; Ole Haagen Nielsen
Journal:  J Mol Med (Berl)       Date:  2013-02-01       Impact factor: 4.599

4.  Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis.

Authors:  Daniele De Filippis; Giuseppe Esposito; Carla Cirillo; Mariateresa Cipriano; Benedicte Y De Winter; Caterina Scuderi; Giovanni Sarnelli; Rosario Cuomo; Luca Steardo; Joris G De Man; Teresa Iuvone
Journal:  PLoS One       Date:  2011-12-06       Impact factor: 3.240

5.  Huanglian Jiedu Decoction ameliorates DSS-induced colitis in mice via the JAK2/STAT3 signalling pathway.

Authors:  Zhuo Lu; Wanna Xiong; Simeng Xiao; Yilong Lin; Kai Yu; Guihua Yue; Qiaoming Liu; Fang Li; Jianqin Liang
Journal:  Chin Med       Date:  2020-05-08       Impact factor: 5.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.